Evolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment
Eugene E. Wright, Savitha Subramanian
Abstract
Numerous studies have demonstrated the clinical benefits of continuous glucose monitoring (CGM) use in individuals with type 1 diabetes and type 2 diabetes (T2D) who are treated with intensive insulin therapy. A growing body of evidence suggests that CGM use may also confer similar glycemic benefits in T2D individuals who are treated with less-intensive therapies. Investigators are also exploring the potential use of CGM as an aid in weight management. This article reviews the continuing evolution of CGM, focusing on how CGM may be used to improve glycemic control and promote adoption of desired health behaviors within broader T2D and prediabetes populations.
Topics & Concepts
MedicineGlycemicPrediabetesContinuous glucose monitoringIntensive care medicineType 2 diabetesInsulinDiabetes mellitusDiabetes managementType 1 diabetesBlood Glucose Self-MonitoringInternal medicineEndocrinologyDiabetes Management and ResearchPancreatic function and diabetesDiabetes Treatment and Management